Clinical Trial Update: A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing interchangeability between TRS003 and Bevacizumab for metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• TRS003

Snippet

Sponsor: Zhejiang Teruisi Pharmaceutical Inc. | Conditions: Metastatic Colorectal Cancer (CRC) | Phase 3 | Status: UNKNOWN